PD-L1 up-regulation in melanoma increases disease aggressiveness and is mediated through miR-17-5p
Sign Up to like & getrecommendations! Published in 2017 at "Oncotarget"
DOI: 10.18632/oncotarget.15213
Abstract: PD-L1 is expressed by a subset of patients with metastatic melanoma (MM) with an unfavorable outcome. Its expression is increased in cells resistant to BRAF or MEK inhibitors (BRAFi or MEKi). However, the function and… read more here.
Keywords: mir; expression; brafi meki; regulation melanoma ... See more keywords